In a recent Shark Tank India episode, judges were impressed by an entrepreneur's pitch for a hair loss reduction device for cancer patients. Priced at Rs 13 lakhs, it offers replaceable haircaps to ease chemotherapy stress.
Seeking Rs 30 lakh for 1.2% equity, he aimed for FDA approval in the US to expand globally. Despite a Rs 25 crore valuation, judges questioned the modest ask.
The entrepreneur's response, "I want FDA approval in the United States," resonated. With a vision for Rs 50 crore valuation next year and Rs 100 crore in five, judges collectively invested Rs 30 lakh for 1.8% equity, pleasing the entrepreneur.